Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | glycogen phosphorylase | 0.0111 | 0.4026 | 0.3906 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.0111 | 0.4026 | 1 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0111 | 0.4026 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | glycogen phosphorylase | 0.0111 | 0.4026 | 0.4026 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.0111 | 0.4026 | 0.3906 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0778 | 0.152 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0111 | 0.4026 | 1 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0051 | 0.0196 | 0.0196 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.0111 | 0.4026 | 1 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0051 | 0.0196 | 0.0196 |
Echinococcus granulosus | glycogen phosphorylase | 0.0111 | 0.4026 | 0.3906 |
Schistosoma mansoni | coup transcription factor | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | thyroid hormone receptor | 0.0051 | 0.0196 | 0.0196 |
Schistosoma mansoni | nuclear hormone receptor | 0.0051 | 0.0196 | 0.0196 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0778 | 0.152 |
Schistosoma mansoni | thyroid hormone receptor | 0.0051 | 0.0196 | 0.0196 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0111 | 0.4026 | 0.3906 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0778 | 0.152 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.0111 | 0.4026 | 0.3906 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0778 | 0.152 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0051 | 0.0196 | 0.0196 |
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0111 | 0.4026 | 0.5 |
Echinococcus granulosus | glycogen phosphorylase | 0.0111 | 0.4026 | 0.3906 |
Brugia malayi | carbohydrate phosphorylase | 0.0111 | 0.4026 | 1 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0111 | 0.4026 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Giardia lamblia | Glycogen phosphorylase | 0.0111 | 0.4026 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.0111 | 0.4026 | 0.4026 |
Mycobacterium ulcerans | glycogen phosphorylase GlgP | 0.0048 | 0 | 0.5 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0051 | 0.0196 | 0.0196 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0111 | 0.4026 | 0.5 |
Mycobacterium tuberculosis | Probable glycogen phosphorylase GlgP | 0.0048 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.6109 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.7865 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.